The findings were consistent with the results of a previous study (16) that indicated that FAT4 deficiency may lead to uncontrolled tumor progression and unfavorable clinical outcome in hepatocellular carcinoma. This evidence concerns the gene FAT4 and hepatocellular carcinoma.